Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. A coronary guidewire is used to navigate catheters during angiography and Percutaneous Coronary Interventions (PCIs). GlobalData uses proprietary data and analytics to provide a comprehensive report on the coronary guidewires market in Israel. Buy the latest report here.

Smarter leaders trust GlobalData

In 2022, GlobalData’s Market Model methodology determined that the leading player in the coronary guidewires market in Israel was Abbott Laboratories followed by B. Braun Melsungen, Biotronik SE & Co, Boston Scientific, Cook Medical, Koninklijke Philips, Medtronic and Opsens.

Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.

The guidewire has an elongated body which provides flexibility and a distal tip. Generally, a coronary guidewire has three parts: central core, outer covering and flexible distal tip. The core is made of either stainless steel, dura steel or nitinol. The coating on guidewire may be either hydrophilic or hydrophobic. A standard coronary guidewire has an elongated body which provides flexibility and a distal tip. Generally, a coronary guidewire has three parts: a central core, an outer covering and a flexible distal tip. The core is made of either stainless steel, dura steel or nitinol. The coating on the guidewire may be either hydrophilic or hydrophobic. FFR Coronary Guidewires, also known as Fractional Flow Reserve Coronary Guidewires, are a specialized type of guidewire that contain an integrated sensor which measures blood pressure and flow within a specific region of a coronary artery during angiography.

The coronary guidewires market in Israel can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.

For the latest analysis of the market size coronary guidewires in Israel, buy the report here.

This content was updated on 26 February 2024

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.